Browse by UCL people
Group by: Type | Date
Jump to: Article
Number of items: 7.
Article
China, L;
Muirhead, N;
Skene, SS;
Shabir, Z;
De Maeyer, RPH;
Maini, AA;
Gilroy, DW;
(2016)
ATTIRE: Albumin To prevenT Infection in chronic liveR failurE: study protocol for a single-arm feasibility trial.
BMJ Open
, 6
(1)
, Article e010132. 10.1136/bmjopen-2015-010132.
|
Cohen, H;
Doré, CJ;
Clawson, S;
Hunt, BJ;
Isenberg, D;
Khamashta, M;
Muirhead, N;
(2015)
Rivaroxaban in antiphospholipid syndrome (RAPS) protocol: a prospective, randomized controlled phase II/III clinical trial of rivaroxaban versus warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Lupus
, 24
(10)
pp. 1087-1094.
10.1177/0961203315581207.
|
Cohen, H;
Hunt, B;
Efythymiou, M;
Arachchillage, D;
Ruiz, M;
Clawson, S;
Muirhead, N;
... Collaborators, RAPST; + view all
(2015)
Raps (rivaroxaban in antiphospholipid syndrome): a prospective randomised controlled phase II/III clinical trial of rivaroxaban vs. warfarin in patients with thrombotic antiphospholipid syndrome, with or without SLE.
Journal of Thrombosis and Haemostasis
, 13
, Article LB003. DOI: 10.1111/jth.12993.
|
Cohen, H;
Hunt, BJ;
Efthymiou, M;
Arachchillage, DR;
Mackie, IJ;
Clawson, S;
Sylvestre, Y;
... RAPS trial investigators, .; + view all
(2016)
Rivaroxaban versus warfarin to treat patients with thrombotic antiphospholipid syndrome, with or without systemic lupus erythematosus (RAPS): a randomised, controlled, open-label, phase 2/3, non-inferiority trial.
Lancet Haematology
, 3
(9)
e426-e436.
10.1016/S2352-3026(16)30079-5.
|
McAteer, MA;
O'Connor, JPB;
Koh, DM;
Leung, HY;
Doran, SJ;
Jauregui-Osoro, M;
Muirhead, N;
... Punwani, S; + view all
(2021)
Introduction to the National Cancer Imaging Translational Accelerator (NCITA): a UK-wide infrastructure for multicentre clinical translation of cancer imaging biomarkers.
British Journal of Cancer
10.1038/s41416-021-01497-5.
(In press).
|
Ng, A;
Khetrapal, P;
Brew‐Graves, C;
Muirhead, N;
Asif, A;
Chan, VW;
Nathan, A;
(2022)
Choosing appropriate patient‐reported outcome measures for prostate disease.
BJUI Compass
10.1002/bco2.136.
(In press).
|
Taylor, S;
Mallett, S;
Bhatnagar, G;
Bloom, S;
Gupta, A;
Halligan, S;
Hamlin, J;
... Zealley, I; + view all
(2014)
METRIC (MREnterography or ulTRasound in Crohn's disease): a study protocol for a multicentre, non-randomised, single-arm, prospective comparison study of magnetic resonance enterography and small bowel ultrasound compared to a reference standard in those aged 16 and over.
BMC Gastroenterol
, 14
, Article 142. 10.1186/1471-230X-14-142.
|